Airvo
Total Payments
$1.1M
Transactions
2
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $1.1M | 1 | 0 |
| 2020 | $3,555 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.1M | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| myAirvo3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home | Fisher & Paykel Healthcare Limited | $1.1M | 0 |
| Sleep and Daytime Use of Humidified Nasal High flow Oxygen in COPD Outpatients | FISHER & PAYKEL HEALTHCARE LIMITED | $3,555 | 0 |
Top Doctors Receiving Payments for Airvo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Philadelphia, PA | $1.1M | 2 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $1.1M
- Total Doctors 0
- Transactions 2
About Airvo
Airvo is a device associated with $1.1M in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is FISHER & PAYKEL HEALTHCARE LIMITED.
Payment data is available from 2020 to 2021. In 2021, $1.1M was paid across 1 transactions to 0 doctors.
The most common payment nature for Airvo is "Unspecified" ($1.1M, 100.0% of total).
Airvo is associated with 2 research studies, including "myAirvo3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home" ($1.1M).